UK Researchers to Use Agilent, Illumina Chips in 12,000-Sample Developmental-Disorders Project
March 29, 2011
UK Researchers to Use Agilent, Illumina Chips in 12,000-Sample Developmental-Disorders Project
Study leader Nigel Carter said that the project will use Agilent Technologies' comparative genomic-hybridization arrays and Illumina's whole-genome SNP-genotyping arrays to gather genetic information on enrolled patients.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In 2010, Array Makers Saw CGH Become the Standard in Cytogenetics, Prepared for Next Wave of GWAS
January 4, 2011 / BioArray News - With Clinical Trials Underway, Agilent Anticipates 2014 FDA Submission for Cyto Array Platform
January 29, 2013 / BioArray News - New ACMG Guidelines Have 'Raised Bar' for Cyto Chips, Array Makers Say
July 26, 2011 / BioArray News - Study Finds Array and Sequencing Combo Yields Novel Info on Gene Expression
June 28, 2011 / In Sequence - At Investor Confab, Illumina Details 'Enormous' DTC Demand as Market Shifts to Less Complex Chips
May 21, 2013 / BioArray News